Surgery Partners Inc (NASDAQ:SGRY)’s share price was up 8.4% during trading on Friday . The stock traded as high as $11.82 and last traded at $11.76, approximately 389,861 shares traded hands during mid-day trading. An increase of 23% from the average daily volume of 317,599 shares. The stock had previously closed at $10.85.
Several equities analysts have commented on SGRY shares. Zacks Investment Research raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Wednesday, October 9th. BidaskClub raised Surgery Partners from a “hold” rating to a “buy” rating in a research report on Thursday, October 24th. Finally, ValuEngine raised Surgery Partners from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. Surgery Partners presently has a consensus rating of “Buy” and an average target price of $13.50.
The firm has a market cap of $508.13 million, a P/E ratio of -4.80 and a beta of 2.35. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 2.29. The business has a 50-day moving average price of $7.97 and a 200-day moving average price of $8.16.
In other news, COO Jason Eric Evans acquired 25,000 shares of Surgery Partners stock in a transaction dated Tuesday, August 20th. The stock was purchased at an average cost of $5.95 per share, for a total transaction of $148,750.00. Following the completion of the purchase, the chief operating officer now directly owns 111,655 shares in the company, valued at approximately $664,347.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.30% of the company’s stock.
A number of hedge funds have recently made changes to their positions in SGRY. Royal Bank of Canada raised its position in Surgery Partners by 64.3% during the second quarter. Royal Bank of Canada now owns 5,750 shares of the company’s stock valued at $47,000 after acquiring an additional 2,250 shares in the last quarter. Tower Research Capital LLC TRC purchased a new position in Surgery Partners during the second quarter valued at approximately $57,000. Menta Capital LLC purchased a new position in Surgery Partners during the second quarter valued at approximately $107,000. Jefferies Group LLC raised its position in Surgery Partners by 22.4% during the second quarter. Jefferies Group LLC now owns 19,071 shares of the company’s stock valued at $155,000 after acquiring an additional 3,490 shares in the last quarter. Finally, Rhumbline Advisers raised its position in Surgery Partners by 8.7% during the third quarter. Rhumbline Advisers now owns 34,402 shares of the company’s stock valued at $254,000 after acquiring an additional 2,763 shares in the last quarter. Institutional investors own 94.39% of the company’s stock.
Surgery Partners Company Profile (NASDAQ:SGRY)
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Recommended Story: Net Margin
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.